William Blair Downgrades Cardiff Oncology to Market Perform

Benzinga Newsdesk www.benzinga.com Negative 90.1%

Neg 90.1% Neu 0% Pos 0%

William Blair analyst Andy Hsieh downgrades Cardiff Oncology (NASDAQ:CRDF) from Outperform to Market Perform.

Comments

No comments yet. Be the first!